This indicates that there is an enhanced amount of the IL-6-inducing neo-structure present in cancer patient sera and that such neo-structures are produced selectively in PBMC cultures from cancer patients, probably due to a unique set-up of proteases. The gene discussed is IL6; the disease is cancer.